PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
Clinical trial NCT03176264 · TERMINATED
Trial details
- NCT number
- NCT03176264
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2018-01-30
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.